University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Drug delivery in intervertebral disc degeneration and osteoarthritis : Selecting the optimal platform for the delivery of disease-modifying agents

Simple item page
dc.contributor.authorColella, Fabio
dc.contributor.authorGarcia, João Pedro
dc.contributor.authorSorbona, Marco
dc.contributor.authorLolli, Andrea
dc.contributor.authorAntunes, Bernardo
dc.contributor.authorD'Atri, Domenico
dc.contributor.authorBarré, Florian P.Y.
dc.contributor.authorOieni, Jacopo
dc.contributor.authorVainieri, Maria Letizia
dc.contributor.authorZerrillo, Luana
dc.contributor.authorCapar, Serdar
dc.contributor.authorHäckel, Sonja
dc.contributor.authorCai, Yunpeng
dc.contributor.authorCreemers, Laura B.
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.date.accessioned2020-10-15T19:30:01Z
dc.date.available2020-10-15T19:30:01Z
dc.date.issued2020-12-10
dc.descriptionAcknowledgement We would like to acknowledge Prof. Gerjo Van Osch and prof Molly Stevens for their careful and critical revision of the manuscript. We wish to thank all principal investigators of the TargetCaRe consortium for their enormous support during the years: Prof G. van Osch. Prof. Mauro Alini, Prof. Bruce Caterson, Dr. Alan Chan, Prof. Cosimo De Bari, Prof. Ron Heeren, Prof. Kennet Howard, Prof. Marcelle Machluf, Prof. Molly M. Stevens and Prof. Avner Yayon. This work was supported by European Union's Horizon 2020 Research And Innovation Programme under Marie Sklodowska Curie Grant agreement no. 642414.en
dc.description.statusPeer revieweden
dc.format.extent15
dc.format.extent3014175
dc.format.extent2996946
dc.identifier177826534
dc.identifier2a82ce2e-c46d-4007-95be-adece148a055
dc.identifier85090558186
dc.identifier32860929
dc.identifier000600791600071
dc.identifier.citationColella, F, Garcia, J P, Sorbona, M, Lolli, A, Antunes, B, D'Atri, D, Barré, F P Y, Oieni, J, Vainieri, M L, Zerrillo, L, Capar, S, Häckel, S, Cai, Y & Creemers, L B 2020, 'Drug delivery in intervertebral disc degeneration and osteoarthritis : Selecting the optimal platform for the delivery of disease-modifying agents', Journal of Controlled Release, vol. 328, pp. 985-999. https://doi.org/10.1016/j.jconrel.2020.08.041en
dc.identifier.doi10.1016/j.jconrel.2020.08.041
dc.identifier.issn0168-3659
dc.identifier.urihttps://hdl.handle.net/2164/15232
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85090558186&partnerID=8YFLogxKen
dc.identifier.vol328en
dc.language.isoeng
dc.relation.ispartofJournal of Controlled Releaseen
dc.subjectR Medicineen
dc.subjectPharmaceutical Scienceen
dc.subject.lccRen
dc.titleDrug delivery in intervertebral disc degeneration and osteoarthritis : Selecting the optimal platform for the delivery of disease-modifying agentsen
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
1_s2.0_S016836592030482X_main.pdf
Size:
2.87 MB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
Collella_et_al_Drug_delivery_Journal_of_controlled_release_vor.pdf
Size:
2.86 MB
Format:
Adobe Portable Document Format
Download

Collections

All research